SGH
Sivik Global Healthcare Portfolio holdings
AUM $224M
1-Year Return
5.3%
This Quarter Return
+4.61%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$183M
AUM Growth
+$2.09M
(+1.2%)
Cap. Flow
-$3.72M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
49.86%
Holding
44
New
6
Increased
10
Reduced
9
Closed
13
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
+$6.93M |
| 2 |
Medtronic
MDT
|
+$6.74M |
| 3 |
Baxter International
BAX
|
+$5.99M |
| 4 |
AstraZeneca
AZN
|
+$5.15M |
| 5 |
Gilead Sciences
GILD
|
+$4.48M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$5.24M |
| 2 |
Eli Lilly
LLY
|
+$4.96M |
| 3 |
AbbVie
ABBV
|
+$4.44M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.96M |
| 5 |
UnitedHealth
UNH
|
+$3.93M |
Sector Composition
| 1 | Healthcare | 88.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Avantor
AVTR
$8.66B
| $3.24M | 1.75% |
200,000
| – | – |
|
27
Surgery Partners
SGRY
$2.76B
| $2.97M | 1.61% |
125,000
-75,000
| -38% | -$1.78M |
|
28
West Pharmaceutical
WST
$18.6B
| $2.8M | 1.51% |
+12,500
| New | +$2.8M |
|
|
29
UnitedHealth
UNH
$308B
| $2.62M | 1.42% |
5,000
-7,500
| -60% | -$3.93M |
|
|
30
AbbVie
ABBV
$382B
| – | – |
-25,000
| Closed | -$4.44M |
|
31
Acadia Healthcare
ACHC
$2B
| – | – |
-50,000
| Closed | -$1.98M |
|
32
Alnylam Pharmaceuticals
ALNY
$60.5B
| – | – |
-7,000
| Closed | -$1.65M |
|
33
Bio-Rad Laboratories Class A
BIO
$7.64B
| – | – |
-10,000
| Closed | -$3.29M |
|
|
34
Bristol-Myers Squibb
BMY
$94.3B
| – | – |
-70,000
| Closed | -$3.96M |
|
35
BioNTech
BNTX
$23.9B
| – | – |
-15,000
| Closed | -$1.71M |
|
36
Edwards Lifesciences
EW
$44.1B
| – | – |
-50,000
| Closed | -$3.7M |
|
37
Madrigal Pharmaceuticals
MDGL
$9.52B
| – | – |
0
| – | – |
|
38
Maravai LifeSciences
MRVI
$418M
| – | – |
-140,000
| Closed | -$763K |
|
39
Repligen
RGEN
$6.74B
| – | – |
-10,000
| Closed | -$1.44M |
|
40
Sarepta Therapeutics
SRPT
$1.89B
| – | – |
-10,000
| Closed | -$1.22M |
|
|
41
Vertex Pharmaceuticals
VRTX
$100B
| – | – |
-13,000
| Closed | -$5.24M |
|
42
Zimmer Biomet
ZBH
$19.6B
| – | – |
-20,000
| Closed | -$2.11M |
|
43
Zoetis
ZTS
$65.4B
| – | – |
-15,000
| Closed | -$2.44M |
|